Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation Versus Temozolomide in Preventing Brain Metastases in Limited Stage Small Cell Lung Cancer

NCT02605811 is registered in ClinicalTrials.gov with Guangzhou Medical University as lead sponsor.

NCT NCT02605811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02605811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation Versus Temozolomide in Preventing Brain Metastases in Limited Stage Small Cell Lung Cancer
Lead sponsor
Guangzhou Medical University
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2015
Completion date
December 31, 2021
Enrollment
426 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic carcinoma, small cell lung cancer